These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34928388)

  • 21. Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population.
    Aksun S; Sonu NC; Aygun S; Karakulak UN; Mumusoglu S; Yildiz BO
    J Endocrinol Invest; 2024 May; 47(5):1129-1137. PubMed ID: 37930586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 24. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
    Liang P; Xi L; Shi J; Li W; Zhao S; Deng Y; Wang R; Sun Y; Gu B; Yuan L; Zhang Y; Gu W; Wang W; Hong J
    Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis.
    Greenwood EA; Yaffe K; Wellons MF; Cedars MI; Huddleston HG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2809-2819. PubMed ID: 30985868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study.
    Kluzek S; Rubin KH; Sanchez-Santos M; O'Hanlon MS; Andersen M; Glintborg D; Abrahamsen B
    Arthritis Res Ther; 2021 Aug; 23(1):225. PubMed ID: 34461982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
    Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data.
    Kujanpää L; Arffman RK; Pesonen P; Hurskainen E; Järvelin MR; Franks S; Tapanainen JS; Morin-Papunen L; Piltonen TT
    Eur J Endocrinol; 2024 Jun; 190(6):409-420. PubMed ID: 38781435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
    Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE
    Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
    Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the Risk of Metabolic Syndrome in Adolescents with Normal BMI who have Polycystic Ovary Syndrome?
    Aydin Y; Hassa H; Burkankulu D; Arslantas D; Sayiner D; Ozerdogan N
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):271-4. PubMed ID: 26049937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.
    Ding T; Baio G; Hardiman PJ; Petersen I; Sammon C
    BMJ Open; 2016 Jul; 6(7):e012461. PubMed ID: 27401369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women?
    Coney P; Ladson G; Sweet S; Legro RS
    Semin Reprod Med; 2008 Jan; 26(1):35-8. PubMed ID: 18181080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
    Li R; Zhang Q; Yang D; Li S; Lu S; Wu X; Wei Z; Song X; Wang X; Fu S; Lin J; Zhu Y; Jiang Y; Feng HL; Qiao J
    Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
    Kumarendran B; O'Reilly MW; Manolopoulos KN; Toulis KA; Gokhale KM; Sitch AJ; Wijeyaratne CN; Coomarasamy A; Arlt W; Nirantharakumar K
    PLoS Med; 2018 Mar; 15(3):e1002542. PubMed ID: 29590099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
    Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
    Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS.
    Altintas KZ; Dilbaz B; Cirik DA; Ozelci R; Zengin T; Erginay ON; Dilbaz S
    Ginekol Pol; 2017; 88(6):289-295. PubMed ID: 28727126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.